CorVel Co. (NASDAQ:CRVL) Position Raised by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC boosted its stake in CorVel Co. (NASDAQ:CRVL - Free Report) by 199.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,343 shares of the business services provider's stock after purchasing an additional 3,558 shares during the period. Steward Partners Investment Advisory LLC's holdings in CorVel were worth $594,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Advisors Asset Management Inc. raised its stake in shares of CorVel by 121.7% during the third quarter. Advisors Asset Management Inc. now owns 204 shares of the business services provider's stock valued at $67,000 after purchasing an additional 112 shares during the period. Point72 DIFC Ltd purchased a new stake in CorVel during the 3rd quarter worth $88,000. Fifth Third Bancorp lifted its holdings in CorVel by 45.9% in the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock worth $36,000 after buying an additional 101 shares in the last quarter. Jones Financial Companies Lllp purchased a new position in CorVel in the 4th quarter valued at about $37,000. Finally, US Bancorp DE boosted its position in CorVel by 225.4% in the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider's stock valued at $43,000 after buying an additional 266 shares during the last quarter. 51.36% of the stock is owned by hedge funds and other institutional investors.

CorVel Stock Down 0.4 %

Shares of CorVel stock traded down $0.44 on Monday, hitting $106.21. 72,738 shares of the company's stock traded hands, compared to its average volume of 105,604. CorVel Co. has a 52-week low of $76.20 and a 52-week high of $128.61. The stock has a market cap of $5.45 billion, a P/E ratio of 62.48 and a beta of 1.06. The firm's 50-day moving average is $112.21 and its 200 day moving average is $114.21.

Remove Ads

CorVel (NASDAQ:CRVL - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Analyst Ratings Changes

Separately, StockNews.com cut CorVel from a "buy" rating to a "hold" rating in a research note on Thursday.

Insider Transactions at CorVel

In other news, CFO Brandon O'brien sold 1,523 shares of CorVel stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total value of $182,089.88. Following the completion of the transaction, the chief financial officer now directly owns 17,142 shares of the company's stock, valued at approximately $2,049,497.52. The trade was a 8.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Steven J. Hamerslag sold 10,000 shares of the business's stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the sale, the director now directly owns 314,000 shares of the company's stock, valued at approximately $38,772,720. This represents a 3.09 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,200 shares of company stock valued at $3,824,115. Insiders own 47.57% of the company's stock.

About CorVel

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.